1. Home
  2. Congress bites dust in Udupi dist; BJP sweeps all five constituencies

Congress bites dust in Udupi dist; BJP sweeps all five constituencies

coastaldigest.com news network
May 15, 2018

Udupi, May 15: The Bharatiya Janata Party (BJP) has made a clean sweep by winning all the five Assembly Constituencies in Udupi district in the 2018 State Assembly elections, the results of which were announced here on Tuesday.

Constituency

Congress

BJP

JDS

Others

Udupi

Pramod Madhwaraj
59643

Raghupati Bhat
67996

Birthi Gangadhar Bhandary
627

0

Kaup

Vinay Kumar Sorake
39038

Lalaji R Mendon
48014

Mansoor Ibrahim
0

Anupama Shenoy (BJC)
880

Kundapur

Rakesh Malli
44771

Halady Srinivas Shetty
98444

Prakash Shetty
1406

0

Karkala

Gopal Bhandary
48679

Sunil Kumar
91245

0

Uday Kumar (BSP)
1348

Byndoor

Gopal Poojary
53185

Sukumar Shetty
67392

Ravi Shetty
768

0

In fact, the victory of the BJP was emphatic in all the five Assembly constituencies. The BJP not only retained the Karkala Assembly constituency, but wrested three seats — Udupi, Byndoor and Kaup from the Congress.

Such was the scale of its victory that even the Minister of State for Fisheries, Youth Empowerment and Sports, Pramod Madhwaraj, had to taste defeat at the hands of his classmate of school days, K. Raghupati Bhat, by a margin of 12,044 votes.

Mr. Bhat polled 84,946 votes, while Mr. Madhwaraj secured 72,902 votes.

Halady Srinivas Shetty, the four-term MLA from Kundapur, who returned to the BJP fold, defeated his nearest rival from the Congress party and president of State unit of Indian National Trade Unions Congress (INTUC), Rakesh Malli, by a margin of 56,405 votes, the highest margin in the district. This is Mr. Shetty’s fifth consecutive win from the constituency.

In fact Mr. Shetty improved his victory margin of 40,611 votes in 2013 Assembly elections, which was the highest margin of victory in the district in that polls.

Mr. Shetty polled 1,03,434 votes, while Mr. Malli received 47,029 votes.

Thekkatte Prakash Shetty of Janata Dal (Secular) got 2,712 votes. In Karkala Assembly constituency, the three-term BJP MLA, V. Sunil Kumar, defeated H. Gopal Bhandary of Congress party by a margin of 42,566 votes.

B.M. Sukumar Shetty, BJP candidate, won the Byndoor Assembly constituency seat by defeating Congress candidate, K. Gopal Poojary, who had won four times from this constituency, by a margin of 24,393 votes.

Anupama Shenoy, former Deputy Superintendent of Police and Secretary of Bharatiya Janashakti Congress, and the lone woman candidate in Assembly elections in Udupi district, came third place by getting 1,634 votes.

Comments

Ibrahim Kaleel
 - 
Tuesday, 15 May 2018

Kapu constituencie JDS candidate " Mansoor Ibrahim" here mention zero vote.... where is self vote? mostly all candidate voting respective same party only....but here vote polling for him..? how come? something wrong in EVM!!

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 2,2020

Mangaluru, Jun 2: The Karnataka Muzarai department, whose main income comes through temple and other religious places of worship, has incurred a loss of Rs 600 Crore in revenue during the lock-down, Minister for Muzrai Kota Srinivas Poojary said on Monday.

Addressing reporters here, he said the Kollur Sri Mookambika temple alone lost revenue of about Rs 14 crore it was earning during April and May.

Around 300 A and B grade temples under Muzrai (Hindu religious institutions and charitable endowments) department in the State lost around 35 per cent of their annual income, he said.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 6,2020

Bengaluru, Jun 6: Karnataka Chief Minister B S Yediyurappa on Saturday said hotels and restaurants would be allowed to re-open, but the precautionary measures laid down by the Centre against coronavirus were mandatory.

The Chief Minister on Friday held a meeting with the tourism and transport department, also stakeholders, regarding revival of tourism in the state.

Hotels associations and transport companies have said they would follow the guidelines issued by the government, an official press release said here.

The Karnataka government had said it would go by the Centre's direction on opening religious places of worship, shopping malls, hotels, restaurants and other hospitality services on June 8.

Buses, hotels and taxi owners association placed some demands at the meeting, the release said, adding that Yediyurappa informed them that he would examine their demands and take appropriate decisions.

The Chief Minister also released a handout regarding the guidelines that need to be followed as the tourism department is opening hotels, guest houses and tourist destinations.

Deputy Chief Minister Laxman Savadi, Tourism Minister C T Ravi and senior officials of the department participated in the meeting.

The government had, on Thursday, said safaris, trekking, jungle lodges and resorts in areas that fall outside the COVID-19 containment zones can re-open provided they adhere to social distancing, hygiene as issued by the governments.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 16,2020

University of Oxford researchers have claimed that a cheap and widely available drug called dexamethasone can help save the lives of patients who are seriously ill with coronavirus.

Scientists working on the Recovery Trial found the drug could help patients on ventilators and oxygen, but had no effect on those who did not need help breathing.

“Based on these results, one death would be prevented by treatment of around eight ventilated patients or around 25 patients requiring oxygen alone,” researchers said in a statement.

Matt Hancock, the health secretary, tweeted: “This global first exemplifies the power of science.”

“I’m absolutely delighted that today we can announce the first successful clinical trial for a treatment for Covid-19,” Mr Hancock said.

Recovery Trial experts said a randomised group of 2,104 patients was given 6mg of dexamethasone per day for 10 days, while another group of 4,321 were given normal treatment.

Dexamethasone reduced deaths by one-fifth in patients on oxygen feeds and by one-third in those who needed a ventilator to breathe, preliminary results showed.

Mr Hancock added: “This is a huge step forward and it’s because we’ve backed the science.”

Martin Landray, professor of medicine and epidemiology at the Nuffield Department of Population Health, University of Oxford, and one of the trial’s chief investigators, said in a statement: “These preliminary results from the Recovery Trial are very clear – dexamethasone reduces the risk of death among patients with severe respiratory complications.

“Covid-19 is a global disease – it is fantastic that the first treatment demonstrated to reduce mortality is one that is instantly available and affordable worldwide.”

Comments

kushal kumar
 - 
Thursday, 18 Jun 2020

Trials  of  drug  dexamethasone   in  Covid-19  cases   have  brought  success  in  saving  lives  ,  claim  Oxford  University  scientists  on  16 June  2020. 

              According  to  news  reports  on  16 June  , 2020  ,   Oxford  University  Scientists  have  conducted  trials  on  anti-inflammatory  steroid  Dexamethasone   in  Covid-19  cases.  Results  released  by  the   Oxford  University    on  16  June  2020  say  that  the   low-cost  and  easily  available  drug  saves  the  people  seriously  infected  by   Coronavirus  ,  cuts  the  death  risk  by  a  third  for  those  on  ventilators  and  by  a  fifth  for  those  on  oxygen.  The  commentary   on  the  drug   reads  like  this  :-

“  This  is  a  tremendous  news  today  from  the  recovery  trial  showing  that  dexamethasone   is  the  first  drug  to  reduce  mortality  from  Covid-19.  It  is  particularly  exciting  as  this  is  an  inexpensive  widely  available  medicine.  This  is  a  ground  breaking  development  in  our  fight  against  the  disease  and  the  speed  at  which  researchers  have  progressed  finding  an  effective  treatment  ,  is  truly  remarkable.  It  shows  importance  of  doing  high  quality  clinical  trials  and  basing  decisions  as  the  results  of  those  trials”. 

               Covid-19  has  taken  into  its  grip   the  entire  world  during  first  half  of  the  year  2020  ,  infecting   lacs  and  killing  also  lacs  of   its  patients.  In  the  absence  of  an  effective  drug  or  vaccine  ,  people  had  no  choice  other  than   to   look   up   to  the  heavens  or   scientists  to  come  with  some  cure.  And  the  drug  described  here  is  the  first  one  to  respond  to  the  prayer   of  the  global  community  ,  it  seems.     As  regards  a  vaccine  ,   only  few  are  claiming  that  it  can  come  by  the  end  of  the  present  year  2020.  Rather   ,  some  are  of  the  view  that  it  may  take  a  larger  part  of  the  year  2021  and   could   even  go    to  mid-2022.   Whatever  that  scenario  about  prospect  of  arrival  of  vaccine  to  treat  Covid-19  may  be   ,  the  news  that  was  broken   on  16  June  2020   by   the  Oxford  University   scientists   in  relation  to   drug  dexamethasone   would  have  sent  a  wave  of   strength  and  hope   among   people  world-wide.  And  this  Vedic  astrology  writer  was  spirited  for  another  reason  as   well   -  a  prediction  of   when  some  relief   by  way  of  drug  to  fight  Covid-19   may  appear  ,   having  come  accurate  in   the   claim  announced  by  Oxford  University   on  16 June  2020.  This  writer  had  ,   based   on  interpretation  and  application   of  Vedic  astrology  ,   contributed  in  early  April  ,  2020   an  opinion  piece     - “  Some  searchlight  on  way  out  of  Covid-19  presently  tormenting  mankind” -   to  a  number  of   newspapers.  It  was  also  contributed  on  11  April  ,  2020   using  the  ‘ comments’   column  of  article  -‘ Heard  Charles  took   Ayurveda  treatment-based  Ayush  drugs  for   Covid-19’  -   at   theprint.in/india/looking-at-evidence-based-ayush-medicines-to-treat-covid-19-minister-shripad-naik/393407/.   The  text  in  the  opinion  piece  related  to  the  claim  of  success  announced  by  Oxford  University  scientists  on  16 June  ,  2020  ,  reads  like  this  :- 

“  So  reading  in  between  the  lines  ,  it  can  be  said  that  some  effective  drug   or  remedy  can  arrive  by   mid   or  towards   the  last  week  of  June  2020   to   provide  some  relief  during  July  to  September  2020 ,  to  some  good  extent”.

The  point  this  writer  wants  to  share  with  readers  world-wide  is  that   yes  ,  a  drug   envisaged  in  the  aforesaid  prediction  has  appeared  on  the  horizon  in  the  claim  announcement  of  Oxord  University  scientists  on  16  June ,  2020. 

Bio  :-

 

Kushal  kumar  ,

202-GH28  ,  Mansarovar   Apartments  ,

Sector  20  ,  Panchkula-134116  ,  Haryana,

India.

Note  :-  This  writer’s    significant  predictive  work  covering   2020   about   the  U.S.  and  Italy

 

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.